Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... medical care for Americans with "morbid obesity," a chronic medical condition of genetic, environmental and behavioral origins where the amount of excess weight is often more ... through methods that are effective for the moderately obese -- diet, exercise, behavior modification and drug therapy. Although these interventions work in some significantly overweight ...
2009 NOV 29 ... make lasting changes to the DNA of a mosquito. Now, Dimopoulos and his team are using genetic modification (GM) to permanently manipulate this particular molecular pathway so that mosquitoes' ...
2009 NOV 23 ... Compugen Ltd. (NASDAQ:CGEN) announced the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to type 2 diabetes, the most common form of ... high-risk patients may benefit from more aggressive management either through lifestyle modification or drug treatment. There are an estimated 24 million people in the U.S. with diabetes, ...
2009 NOV 9 ... enzyme prodrug therapy (GDEPT) and has recently entered clinical trials. It requires the genetic modification of tumor cells to express the E. coli enzyme nitroreductase that bioactivates the ...
2009 NOV 24 ... deleting undesirable traits. Chromatin's Mini-Chromosomes are autonomous genetic elements built to deliver multiple traits of importance to growers, processors, and ... simplified plant breeding in plants. Those technical solutions are site-specific genome modification and building of customized chromosomes." Dow AgroSciences' EXZACT™ ...
2009 NOV 16 ... were not disclosed. This technology, combining a recombinase system with genetic modification, is the only one allowing the creation of inducible mutations. Indeed, the Flex ...
2009 NOV 23 ... produce at clinical grade," investigators in the United States report. "Genetic modification of T cells using transposons Lis integrating plasmids is an attractive alternative ...
2009 NOV 17 ... sensitive to RNAi triggers than wild-type cells has significant implications for reverse genetic analyses in this important human pathogen." Patrick and colleagues ... and TbDCL2 carry a 5'-monophosphate and a blocked 3' terminus, suggesting that 3' end modification is an ancient trait of siRNAs. We thus propose a model whereby TbDCL2 fuels the T. ...
2009 NOV 3 ... Drive, Rockville, MD 20855, USA. Keywords: South Korea, Life Sciences, Genetic Modification, Gene Therapy, Treatment, Medical Device, Botany, Plant Cell Research, Pohang University ...
2009 NOV 23 ... leukemia,' have been published. "Chronic myeloid leukemia is defined by the acquired genetic mutation, t(9;22), which leads to the fusion-protein BCR-ABL. Prior to the development ... of the BCR-ABL-mediated transcription, protein synthesis or post-translational modification, all of which lead to decreased proliferation and malignant cell death." ...
2009 NOV 23 ... often involves the post-translational modification of cargo proteins. Using a genetic screen of random peptides, we have previously identified a group of C-terminal ...
2009 NOV 2 ... USA population aged >60 years. It is unclear whether this reflects selection bias, genetic protection from prostate cancer among patients with DM, or both," wrote S. Loeb and ... and prostate cancer aggressiveness. Specifically, we sought to evaluate for effect modification between DM, a newly discovered prostate cancer susceptibility locus on chromosome 17q12 ...
2009 NOV 3 ... suggest that E2 treatment induces ovarian development in the bipotential gonads of genetic males by modification of gonadal somatic cells and E2 production, mediated by CYP19A." ...
2009 NOV 2 ... According to recent research from the United States, "Risk assessment coupled with genetic counseling and testing for the cancer predisposition genes BRCA1 and BRCA2 (BRCA1/2) has ... breast and ovarian cancer (HBOC). For mutation carriers, several options for risk modification have achieved substantial reductions in future cancer risk." "However, ...
2009 NOV 27 ... "This paper presents an application of elitist nondominated sorting genetic algorithm version II (NSGA-II), a multi-objective algorithm to a constrained single ... performance of the NSGA-II, two modifications are proposed. In problem formulation the modification is virtual mapping procedure (VMP), and in NSGA-II algorithm, controlled elitism is ...
2009 NOV 16 ... Signs Definitive Agreement with Panomics Sanofi-Aventis to Use Regeneron's Genetic Modification Method Monsanto to Build DEKALB Corn Seed Production Facility ...
